| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |